113 related articles for article (PubMed ID: 30945386)
1. Plasma CADM1 promoter hypermethylation and D-dimer as novel metastasis predictors of cervical cancer.
Rong G; Zhang M; Xia W; Li D; Miao J; Wang H
J Obstet Gynaecol Res; 2019 Jul; 45(7):1251-1259. PubMed ID: 30945386
[TBL] [Abstract][Full Text] [Related]
2. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
[TBL] [Abstract][Full Text] [Related]
3. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.
Overmeer RM; Henken FE; Snijders PJ; Claassen-Kramer D; Berkhof J; Helmerhorst TJ; Heideman DA; Wilting SM; Murakami Y; Ito A; Meijer CJ; Steenbergen RD
J Pathol; 2008 Aug; 215(4):388-97. PubMed ID: 18498117
[TBL] [Abstract][Full Text] [Related]
4. Demethylation of CADM1 and SOCS1 using capsaicin in cervical cancer cell line.
Sharan M; Jha M; Chandel R; Syeda S; Mathur R; Jha NK; Jha SK; Goel H; Shrivastava A; Chauhan S; Pamidimarri S; Jha AK
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):649-657. PubMed ID: 36441265
[TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
[TBL] [Abstract][Full Text] [Related]
6. Preoperative D-dimers as an independent prognostic marker in cervical carcinoma.
Luo YL; Chi PD; Zheng X; Zhang L; Wang XP; Chen H
Tumour Biol; 2015 Nov; 36(11):8903-11. PubMed ID: 26071675
[TBL] [Abstract][Full Text] [Related]
7. Comparison of plasma D-dimer and thrombus precursor protein in patients with operable breast cancer as a potential predictor of lymph node metastasis.
Kim HK; Song KS; Lee KR; Kang YH; Lee YJ; Lee ES
Blood Coagul Fibrinolysis; 2004 Jan; 15(1):9-13. PubMed ID: 15166937
[TBL] [Abstract][Full Text] [Related]
8. D-dimer: not just an indicator of venous thrombosis but a predictor of asymptomatic hematogenous metastasis in gastric cancer patients.
Diao D; Wang Z; Cheng Y; Zhang H; Guo Q; Song Y; Zhu K; Li K; Liu D; Dang C
PLoS One; 2014; 9(7):e101125. PubMed ID: 24983619
[TBL] [Abstract][Full Text] [Related]
9. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation in serum and tumors of cervical cancer patients.
Widschwendter A; Müller HM; Fiegl H; Ivarsson L; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
Clin Cancer Res; 2004 Jan; 10(2):565-71. PubMed ID: 14760078
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Zhang C; Jia Y; Jia Y; Zhang X; Li K
Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells.
Woo HJ; Kim SJ; Song KJ; Kim SS; Yoon CH; Choi BS; Rhee JE
Int J Oncol; 2015; 46(6):2656-62. PubMed ID: 25845528
[TBL] [Abstract][Full Text] [Related]
14. Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients.
Leffers M; Herbst J; Kropidlowski J; Prieske K; Bohnen AL; Peine S; Jaeger A; Oliveira-Ferrer L; Goy Y; Schmalfeldt B; Pantel K; Wölber L; Effenberger K; Wikman H
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010947
[TBL] [Abstract][Full Text] [Related]
15. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
16. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
Qin R; Cao L; Wang J; Liu J
Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
[TBL] [Abstract][Full Text] [Related]
17. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
[TBL] [Abstract][Full Text] [Related]
18. High Pre-treatment Plasma D-Dimer Level as a Potential Prognostic Biomarker for Cervical Carcinoma.
Nakamura K; Nakayama K; Ishikawa M; Katagiri H; Minamoto T; Ishibashi T; Ishikawa N; Sato E; Sanuki K; Yamashita H; Komatsu-Fujii T; Kyo S
Anticancer Res; 2016 Jun; 36(6):2933-8. PubMed ID: 27272807
[TBL] [Abstract][Full Text] [Related]
19. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
Blackwell K; Haroon Z; Broadwater G; Berry D; Harris L; Iglehart JD; Dewhirst M; Greenberg C
J Clin Oncol; 2000 Feb; 18(3):600-8. PubMed ID: 10653875
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens.
van den Berg RM; Snijders PJ; Grünberg K; Kooi C; Spreeuwenberg MD; Meijer CJ; Postmus PE; Smit EF; Steenbergen RD
Lung Cancer; 2011 Jun; 72(3):316-21. PubMed ID: 21067843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
